222 related articles for article (PubMed ID: 12352914)
1. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation.
Caballero F; Lopez-Navidad A; Cotorruelo J; Txoperena G
Transplantation; 2002 Aug; 74(4):532-7. PubMed ID: 12352914
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term success of organs transplanted from acute methanol poisoned donors.
López-Navidad A; Caballero F; González-Segura C; Cabrer C; Frutos MA
Clin Transplant; 2002 Jun; 16(3):151-62. PubMed ID: 12010136
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for ecstasy-induced fulminant hepatic failure.
De Carlis L; De Gasperi A; Slim AO; Giacomoni A; Corti A; Mazza E; Di Benedetto F; Lauterio A; Arcieri K; Maione G; Rondinara GF; Forti D
Transplant Proc; 2001 Aug; 33(5):2743-4. PubMed ID: 11498145
[No Abstract] [Full Text] [Related]
4. The old transplant recipient that becomes a liver donor.
Khorsandi SE; Heaton N; Prachalias A
Transpl Int; 2015 Sep; 28(9):1111-2. PubMed ID: 25865110
[No Abstract] [Full Text] [Related]
5. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option.
Garbino J; Henry JA; Mentha G; Romand JA
Vet Hum Toxicol; 2001 Apr; 43(2):99-102. PubMed ID: 11308131
[TBL] [Abstract][Full Text] [Related]
6. Organ Dysfunction and Failure Following Brain Death Do Not Preclude Successful Donation.
Essien EI; Parimi N; Gutwald-Miller J; Nutter T; Scalea TM; Stein DM
World J Surg; 2017 Nov; 41(11):2933-2939. PubMed ID: 28620674
[TBL] [Abstract][Full Text] [Related]
7. Outcome of other organs recovered during in situ split-liver procurements.
Ramcharan T; Glessing B; Lake JR; Payne WD; Humar A
Liver Transpl; 2001 Oct; 7(10):853-7. PubMed ID: 11679982
[TBL] [Abstract][Full Text] [Related]
8. [Acute liver failure following the use of ecstasy (MDMA)].
Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation for fulminant hepatic failure.
Uemoto S; Inomata Y; Sakurai T; Egawa H; Fujita S; Kiuchi T; Hayashi M; Yasutomi M; Yamabe H; Tanaka K
Transplantation; 2000 Jul; 70(1):152-7. PubMed ID: 10919593
[TBL] [Abstract][Full Text] [Related]
10. Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts.
Muiesan P; Girlanda R; Jassem W; Melendez HV; O'Grady J; Bowles M; Rela M; Heaton N
Ann Surg; 2005 Nov; 242(5):732-8. PubMed ID: 16244548
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of controlled, non-heart-beating donor liver transplantation.
Manzarbeitia CY; Ortiz JA; Jeon H; Rothstein KD; Martinez O; Araya VR; Munoz SJ; Reich DJ
Transplantation; 2004 Jul; 78(2):211-5. PubMed ID: 15280680
[TBL] [Abstract][Full Text] [Related]
12. One hundred in situ split-liver transplantations: a single-center experience.
Yersiz H; Renz JF; Farmer DG; Hisatake GM; McDiarmid SV; Busuttil RW
Ann Surg; 2003 Oct; 238(4):496-505; discussion 506-7. PubMed ID: 14530721
[TBL] [Abstract][Full Text] [Related]
13. [Ecstasy-induced fulminant hepatic failure and emergency liver transplantation].
Carrión JA; Escorsell A; Nogué S; Mas A
Med Clin (Barc); 2003 Jun; 121(3):118-9. PubMed ID: 12855141
[No Abstract] [Full Text] [Related]
14. Combined liver-thoracic transplantation: single-center experience with introduction of the 'Liver-first' principle.
Ceulemans LJ; Strypstein S; Neyrinck A; Verleden S; Ruttens D; Monbaliu D; De Leyn P; Vanhaecke J; Meyns B; Nevens F; Verleden G; Van Raemdonck D; Pirenne J
Transpl Int; 2016 Jun; 29(6):715-26. PubMed ID: 27037837
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).
Kramer L; Bauer E; Schenk P; Steininger R; Vigl M; Mallek R
Wien Klin Wochenschr; 2003 Sep; 115(15-16):599-603. PubMed ID: 14531175
[TBL] [Abstract][Full Text] [Related]
16. Auxiliary partial orthotopic living donor liver transplantation as an aid for small-for-size grafts in larger recipients.
Inomata Y; Kiuchi T; Kim I; Uemoto S; Egawa H; Asonuma K; Fujita S; Hayashi M; Tanaka K
Transplantation; 1999 May; 67(10):1314-9. PubMed ID: 10360583
[TBL] [Abstract][Full Text] [Related]
17. Cardiopulmonary bypass with profound hypothermia. An optimal preservation method for multiorgan procurement.
Baumgartner WA; Williams GM; Fraser CD; Cameron DE; Gardner TJ; Burdick JF; Augustine S; Gaul PD; Reitz BA
Transplantation; 1989 Jan; 47(1):123-7. PubMed ID: 2643221
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
Smith CM; Davies DB; McBride MA
Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
[TBL] [Abstract][Full Text] [Related]
19. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
20. Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool.
Stratta RJ; Farney AC; Orlando G; Farooq U; Al-Shraideh Y; Palanisamy A; Reeves-Daniel A; Doares W; Kaczmorski S; Gautreaux MD; Iskandar SS; Hairston G; Brim E; Mangus M; El-Hennawy H; Khan M; Rogers J
Clin Transplant; 2016 Apr; 30(4):380-92. PubMed ID: 26782941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
